Evidence map›Paper›PMID 24760448›Full record

ArticlePharmaceutical research2014

Development of thermostable lyophilized inactivated polio vaccine.

Heleen Kraan, Paul van Herpen, Gideon Kersten, Jean-Pierre Amorij

Abstract read
In one paragraph

Article in Pharmaceutical research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Development of a thermostable microneedle patch for polio vaccination.Drug delivery and translational research · 2019
    Article
  10. Article
  11. Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Article
  13. Article
  14. Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Heleen KraanInstitute of Translational Vaccinology (Intravacc), Antonie van Leeuwenhoeklaan 9, P.O. Box 450, 3720 AL, Bilthoven, The Netherlands.
Paul van Herpen
Gideon Kersten
Jean-Pierre Amorij

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of current study was to develop a dried inactivated polio vaccine (IPV) formulation with minimal loss during the drying process and improved stability when compared with the conventional liquid IPV.

methodsExtensive excipient screening was combined with the use of a Design of Experiment (DoE) approach in order to achieve optimal results with high probability.

resultsAlthough it was shown earlier that the lyophilization of a trivalent IPV while conserving its antigenicity is challenging, we were able to develop a formulation that showed minimal loss of potency during drying and subsequent storage at higher temperatures.

conclusionThis study showed the potential of a highly stable and safe lyophilized polio vaccine, which might be used in developing countries without the need of a cold-chain.

Indexed as

Chemistry, PharmaceuticalDrug StabilityExcipientsFreeze DryingParticle SizePoliovirusPoliovirus Vaccine, InactivatedPoliovirus Vaccine, OralTechnology, PharmaceuticalTemperatureTransition TemperatureExcipientsPoliovirus Vaccine, InactivatedPoliovirus Vaccine, Oral

Identifiers

PMID24760448
PMCPMC4197379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.